Javier Sanz

12.0k total citations · 3 hit papers
199 papers, 7.7k citations indexed

About

Javier Sanz is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Javier Sanz has authored 199 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Cardiology and Cardiovascular Medicine, 73 papers in Pulmonary and Respiratory Medicine and 71 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Javier Sanz's work include Cardiac Imaging and Diagnostics (66 papers), Cardiovascular Function and Risk Factors (58 papers) and Pulmonary Hypertension Research and Treatments (33 papers). Javier Sanz is often cited by papers focused on Cardiac Imaging and Diagnostics (66 papers), Cardiovascular Function and Risk Factors (58 papers) and Pulmonary Hypertension Research and Treatments (33 papers). Javier Sanz collaborates with scholars based in United States, Spain and United Kingdom. Javier Sanz's co-authors include Valentı́n Fuster, Zahi A. Fayad, Mario J. García, Leticia Fernández‐Friera, Borja Ibáñez, Juan J. Badimón, Sanjay Rajagopalan, Santo Dellegrottaglie, Damián Sánchez‐Quintana and Carlos G. Santos‐Gallego and has published in prestigious journals such as Nature, Circulation and The Journal of Cell Biology.

In The Last Decade

Javier Sanz

190 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

2019 474 citations Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez et al. Journal of the American College of Cardiology profile →
Anatomy, Function, and Dysfunction of the Right Ventricle

2019 429 citations Javier Sanz et al. Journal of the American College of Cardiology profile →
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

2021 189 citations Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier Sanz United States	46	4.2k	2.4k	1.9k	1.7k	1.2k	199	7.7k
Vojtěch Melenovský Czechia	47	8.8k 2.1×	2.0k 0.8×	1.5k 0.8×	1.2k 0.7×	868 0.7×	228	11.2k
Stephen G. Worthley Australia	45	4.8k 1.1×	2.1k 0.8×	3.1k 1.6×	2.4k 1.5×	556 0.5×	279	8.0k
Pedro Moreno United States	41	3.3k 0.8×	2.0k 0.8×	3.6k 1.9×	2.0k 1.2×	1.1k 0.9×	203	7.6k
Paul Steendijk Netherlands	53	9.2k 2.2×	2.2k 0.9×	2.5k 1.3×	1.6k 1.0×	933 0.8×	247	11.8k
Henrik Sillesen Denmark	45	3.4k 0.8×	3.6k 1.5×	2.4k 1.3×	1.2k 0.7×	512 0.4×	207	7.4k
Ravi V. Shah United States	52	5.3k 1.3×	1.1k 0.5×	1.3k 0.7×	1.4k 0.8×	2.0k 1.8×	236	9.3k
Masakazu Yamagishi Japan	49	4.8k 1.1×	2.0k 0.8×	4.6k 2.4×	1.9k 1.2×	1.7k 1.5×	428	11.8k
Riemer H. J. A. Slart Netherlands	46	1.8k 0.4×	2.6k 1.1×	2.4k 1.2×	2.8k 1.7×	1.1k 0.9×	388	8.7k
Masahiko Kinoshita Japan	50	6.3k 1.5×	1.1k 0.5×	1.5k 0.8×	1.1k 0.7×	1.4k 1.2×	283	9.6k
Patrick Rossignol France	46	5.0k 1.2×	2.7k 1.1×	1.7k 0.9×	482 0.3×	1.1k 0.9×	273	8.7k

Countries citing papers authored by Javier Sanz

Since Specialization

Citations

This map shows the geographic impact of Javier Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Sanz more than expected).

Fields of papers citing papers by Javier Sanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Sanz. The network helps show where Javier Sanz may publish in the future.

Co-authorship network of co-authors of Javier Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Sanz. A scholar is included among the top collaborators of Javier Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Sanz. Javier Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hadley, Michael S., et al.. (2024). Cardiac Magnetic Resonance for Structural Aortic Valve Stenosis Procedures. Journal of Clinical Medicine. 13(17). 5184–5184. 1 indexed citations

Sanz, Javier, Alexander Hirsch, Alina A. Constantinescu, et al.. (2024). Temporal changes in CT-derived fractional flow reserve in patients after heart transplantation. European Radiology. 35(1). 232–243. 3 indexed citations

Sanz, Javier, et al.. (2023). Primer consenso español sobre el uso de la radioterapia intraoperatoria en el cáncer de mama. Conclusiones del panel de expertos. Revista de Senología y Patología Mamaria. 36(3). 100502–100502. 1 indexed citations

Bienstock, Solomon, et al.. (2023). ‘Is it the same patient?’ Evidence of significant cardiac amyloid regression. European Heart Journal - Cardiovascular Imaging. 25(5). e153–e153.

Devesa, Ana, Valentı́n Fuster, Ravi Vazirani, et al.. (2023). Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis. Diabetes Care. 46(11). 2050–2057. 15 indexed citations

Bienstock, Solomon, Fay Y. Lin, Ron Blankstein, et al.. (2023). Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care. JACC. Cardiovascular imaging. 16(8). 1099–1115. 23 indexed citations

Pedersen, Eva S.L., et al.. (2023). Zehn Jahre Neugeborenen-Screening auf zystische Fibrose in der Schweiz. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.

Devesa, Ana, Juan Martínez‐Milla, Belén Oliva, et al.. (2022). Bone marrow activation in response to metabolic syndrome and early atherosclerosis. European Heart Journal. 43(19). 1809–1828. 35 indexed citations

Santos‐Gallego, Carlos G., Juan Antonio Requena-Ibáñez, Álvaro García‐Ropero, et al.. (2020). Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial. Circulation. 142(Suppl_3).

10.

Rosselló, Xavier, Valentı́n Fuster, Belén Oliva, et al.. (2020). Association Between Body Size Phenotypes and Subclinical Atherosclerosis. The Journal of Clinical Endocrinology & Metabolism. 105(12). 3734–3744. 18 indexed citations

11.

Fernández-Alvira, Juan Miguel, Stuart Pocock, Antonio Fernández‐Ortíz, et al.. (2017). PREDICTIVE VALUES OF THE IDEAL CARDIOVASCULAR HEALTH AND THE FUSTER-BEWAT SCORES FOR DETECTING SUBCLINICAL ATHEROSCLEROSIS IN HEALTHY INDIVIDUALS. Journal of the American College of Cardiology. 69(11). 1678–1678.

12.

Garcı́a, Antonio G., et al.. (2016). Mezclas asfálticas con betunes modificados con nanotubos de carbono. Diseño y propiedades. 20–30. 1 indexed citations

13.

Chan, Christopher T., Tom Greene, Glenn M. Chertow, et al.. (2013). Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling. Clinical Journal of the American Society of Nephrology. 8(12). 2106–2116. 56 indexed citations

14.

Álvarez, Ana García, Leticia Fernández‐Friera, Valentí Fuster, & Javier Sanz. (2010). Papel de las nuevas técnicas de imagen en el diagnóstico de síndrome coronario agudo en urgencias. Emergencias. 22(2). 125–129. 5 indexed citations

15.

Gaztañaga, Juan, Gonzalo Pizarro, & Javier Sanz. (2009). Evaluation of Cardiac Valves Using Multidetector CT. Cardiology Clinics. 27(4). 633–644. 3 indexed citations

16.

Vedanthan, Rajesh, Javier Sanz, & Jonathan L. Halperin. (2009). Bicuspid Pulmonic Valve. Journal of the American College of Cardiology. 54(8). e5–e5. 13 indexed citations

17.

Ibáñez, Borja, S Prat, Walter S. Speidl, et al.. (2007). Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage. Circulation. 115(23). 2909–2916. 117 indexed citations

18.

Fuster, Valentı́n & Javier Sanz. (2007). Hipertensión pulmonar: nuevos conocimientos a través de tecnología de imagen. Revista Española de Cardiología. 60. 2–9. 11 indexed citations

19.

Sanz, Javier, et al.. (2007). Biometría, condición física, fenología reproductora, coloración alar y marcas linguales del bigotudo (Panurus biarmicus) en la Estanca de Escorón (Zaragoza). 2–11. 1 indexed citations

20.

Sanz, Javier. (2002). El nuevo Estatuto de la Sociedad Cooperativa Europea. CIRIEC-España revista de economía pública social y cooperativa. 9–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact